Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Change in Taxes: 2016-2020

Historic Change in Taxes for Summit Therapeutics (SMMT) over the last 1 years, with Dec 2020 value amounting to $884,000.

  • Summit Therapeutics' Change in Taxes rose 165.58% to $884,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $6.6 million, marking a year-over-year increase of 77.28%. This contributed to the annual value of $4.4 million for FY2020, which is 238.90% up from last year.
  • Summit Therapeutics' Change in Taxes amounted to $884,000 in Q4 2020, which was up 165.58% from -$1.3 million recorded in Q4 2019.
  • Summit Therapeutics' 5-year Change in Taxes high stood at $5.5 million for Q3 2019, and its period low was -$2.0 million during Q2 2018.
  • Moreover, its 3-year median value for Change in Taxes was $884,000 (2020), whereas its average is $922,898.
  • Data for Summit Therapeutics' Change in Taxes shows a peak YoY spiked of 165.58% (in 2020) over the last 5 years.
  • Over the past 4 years, Summit Therapeutics' Change in Taxes (Quarterly) stood at -$727,057 in 2016, then reached -$2.0 million in 2018, then reached -$1.3 million in 2019, then skyrocketed by 165.58% to $884,000 in 2020.
  • Its Change in Taxes stands at $884,000 for Q4 2020, versus -$1.3 million for Q4 2019 and $1.6 million for Q4 2019.